tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (DE:IQT0)
MUNICH:IQT0
Germany Market

Inhibikase Therapeutics (IQT0) Stock Investors

Compare
1 Followers
Based on 805,489 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DE:IQT0
On average, investors allocate 0.00% of their portfolios to DE:IQT0
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 805,489 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IQT0

0.8%
Last 7
Days
2.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:IQT0, out of 805,489 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IQT0 Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in IQT0 in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IQT0 Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
4.31%
-0.54%
+3.52%
37.56B
Consumer Cyclical
Viking Therapeutics
3.68%
-0.90%
-2.13%
3.04B
Healthcare
Lucid Group
5.12%
-1.69%
+0.02%
6.53B
Consumer Cyclical
Marathon Digital Holdings
4.86%
-0.50%
-0.18%
5.27B
Financial
Nio
7.47%
-1.05%
-0.69%
7.29B
Consumer Cyclical
Riot Platforms
4.53%
-0.42%
-0.15%
3.57B
Financial
CVS Health
3.99%
-0.98%
-1.28%
83.96B
Healthcare
JD
4.39%
-0.24%
+0.41%
52.01B
Consumer Cyclical
AST SpaceMobile
6.19%
-0.03%
+8.02%
16.40B
Technology
Intuit
2.98%
+0.33%
+6.00%
211.40B
Technology
Based on the activity of 805,489 active portfolios
Open your Smart Portfolio

IQT0 Investor Analysis

DE:IQT0 investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.5%
of DE:IQT0 holders
are under 35
Average Segment Performance
Average P/E Ratio20.53
Beta4.60
Dividend Yield4.09%
DE:IQT0 investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
28.9%
of DE:IQT0 holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.79
Beta11.42
Dividend Yield3.52%
DE:IQT0 investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
60.5%
of DE:IQT0 holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta3.72
Dividend Yield3.81%
Overview of age group and performance of DE:IQT0 stock investors
See who invests in IQT0 according to age group and performance.

FAQ

How many retail Investors hold DE:IQT0?
<0.1% of TipRanks' retail investors hold DE:IQT0 in their portfolios.
    What is DE:IQT0 Investor Sentiment?
    DE:IQT0’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DE:IQT0 in the last 7 days?
      ▲ 0.8% of TipRanks' retail investors changed their holding of DE:IQT0 in the last 7 days.
        What percentage of retail investors changed their holding of DE:IQT0 in the last 30 days?
        ▼ 2.5% of TipRanks' retail investors changed their holding of DE:IQT0 in the last 30 days.
          What is the average age of retail investors who hold DE:IQT0?
          The average age of DE:IQT0 Holders is over 55.
            What other stocks have DE:IQT0 investors also bought?
            DE:IQT0 Investors also bought DKNG, VKTX, LCID, MARA, NIO, RIOT, CVS, JD, ASTS, INTU.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis